MYLIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.177560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.811040E-01
Normal-vs-Stage2
1.384070E-02
Normal-vs-Stage3
1.347420E-01
Normal-vs-Stage4
3.721600E-01
Stage1-vs-Stage2
5.498800E-01
Stage1-vs-Stage3
1.632230E-01
Stage1-vs-Stage4
6.798600E-01
Stage2-vs-Stage3
4.195100E-03
Stage2-vs-Stage4
2.820200E-01
Stage3-vs-Stage4
1.686390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.395500E-03
Normal-vs-AfricanAmerican
2.976200E-01
Normal-vs-Asian
9.595700E-02
Caucasian-vs-AfricanAmerican
1.099230E-01
Caucasian-vs-Asian
8.377200E-01
AfricanAmerican-vs-Asian
3.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.320420E-02
Normal-vs-Female
1.530340E-02
Male-vs-Female
3.102000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.903820E-01
Normal-vs-Age(41-60Yrs)
4.292400E-02
Normal-vs-Age(61-80Yrs)
8.918400E-03
Normal-vs-Age(81-100Yrs)
1.157770E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.816000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.523800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.447400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.204020E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.856200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.564400E-03
Normal-vs-Daily Drinker
1.360200E-03
Normal-vs-Weekly Drinker
2.608300E-02
Normal-vs-Occasional Drinker
1.646410E-02
Normal-vs-Social Drinker
8.958000E-02
Non Drinker-vs-Daily Drinker
2.862600E-01
Non Drinker-vs-Weekly Drinker
7.456600E-01
Non Drinker-vs-Occasional Drinker
8.911600E-01
Non Drinker-vs-Social Drinker
5.004400E-01
Daily Drinker-vs-Weekly Drinker
6.087200E-01
Daily Drinker-vs-Occasional Drinker
2.732600E-01
Daily Drinker-vs-Social Drinker
1.513960E-01
Weekly Drinker-vs-Occasional Drinker
6.931800E-01
Weekly Drinker-vs-Social Drinker
4.555000E-01
Occasional Drinker-vs-Social Drinker
6.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.409620E-01
Normal-vs-Grade 2
9.859700E-02
Normal-vs-Grade 3
1.092980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.101800E-01
Grade 1-vs-Grade 3
3.580200E-01
Grade 1-vs-Grade 4
1.409620E-01
Grade 2-vs-Grade 3
2.156300E-02
Grade 2-vs-Grade 4
9.859700E-02
Grade 3-vs-Grade 4
1.092980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.706300E-02
Normal-vs-NonDiabetic
3.161100E-03
Diabetic-vs-NonDiabetic
7.859800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.551800E-02
Normal-vs-NoPancreatitis
5.535900E-03
Pancreatitis-vs-NoPancreatitis
3.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.079700E-02
Normal-vs-N1
9.916000E-03
N0-vs-N1
4.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.717500E-03
Normal-vs-TP53-NonMutant
1.758600E-01
TP53-Mutant-vs-TP53-NonMutant
8.151600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
